Mode
Text Size
Log in / Sign up
N/A N=139 Treatment

Automatic Control of Total Intravenous Anesthesia (ACTIVA)

Anesthesia

Enrolled (actual)
139
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: Depth of Hypnosis Adequacy — 79.4; 16.2 percentage of maintenance duration

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Automatic closed-loop anesthesia (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Primary completion
Apr 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Depth of Hypnosis Adequacy
79.4; 16.2
SECONDARY
Number of Participants for Which the System Showed Dysfunctions
8; 8; 123
SECONDARY
Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score
0; 0; 0; 0; 0; 0
SECONDARY
Effect of Drugs Delivery on Heart Rate
99.7; 0.3
SECONDARY
Effect of Drugs Delivery on Mean Arterial Pressure (MAP)
79.0; 15.7
SECONDARY
Postoperative Heart Rate Stability
72; 74; 74; 74; 72
SECONDARY
Postoperative Mean Arterial Pressure (MAP) Stability
82; 83; 85; 90; 88
SECONDARY
Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score
97; 40; 2; 0; 115; 24
SECONDARY
Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score
136; 3; 0; 0; 133; 4
SECONDARY
Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score
92; 4; 7; 6; 13; 6

Summary

This study concerns the clinical evaluation of a closed loop control system for the automatic administration of anesthetic drugs in TIVA (Total Intra Venous Anesthesia). The purpose of the experimentation is to demonstrate that the control system under study is reliable, safe, applicable and capable of inducing and maintaining an optimal anesthetic level.

Eligibility Criteria

Inclusion Criteria

  • Adult patients undergoing total intravenous general anesthesia for elective surgery

Exclusion Criteria

  • Patients under the age of 18
  • Patients incapable of giving consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04432974). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search